Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Acquired mutations in GATA1 in the megakaryoblastic leukemia of Down syndrome.

Wechsler J, Greene M, McDevitt MA, Anastasi J, Karp JE, Le Beau MM, Crispino JD.

Nat Genet. 2002 Sep;32(1):148-52.

PMID:
12172547
2.

Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.

Rainis L, Bercovich D, Strehl S, Teigler-Schlegel A, Stark B, Trka J, Amariglio N, Biondi A, Muler I, Rechavi G, Kempski H, Haas OA, Izraeli S.

Blood. 2003 Aug 1;102(3):981-6.

3.

Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.

Xu G, Nagano M, Kanezaki R, Toki T, Hayashi Y, Taketani T, Taki T, Mitui T, Koike K, Kato K, Imaizumi M, Sekine I, Ikeda Y, Hanada R, Sako M, Kudo K, Kojima S, Ohneda O, Yamamoto M, Ito E.

Blood. 2003 Oct 15;102(8):2960-8.

4.

GATA1 mutations in transient leukemia and acute megakaryoblastic leukemia of Down syndrome.

Hitzler JK, Cheung J, Li Y, Scherer SW, Zipursky A.

Blood. 2003 Jun 1;101(11):4301-4.

5.

Natural history of GATA1 mutations in Down syndrome.

Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O'Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P.

Blood. 2004 Apr 1;103(7):2480-9.

6.

GATA1, cytidine deaminase, and the high cure rate of Down syndrome children with acute megakaryocytic leukemia.

Ge Y, Stout ML, Tatman DA, Jensen TL, Buck S, Thomas RL, Ravindranath Y, Matherly LH, Taub JW.

J Natl Cancer Inst. 2005 Feb 2;97(3):226-31.

PMID:
15687366
7.

Developmental stage-selective effect of somatically mutated leukemogenic transcription factor GATA1.

Li Z, Godinho FJ, Klusmann JH, Garriga-Canut M, Yu C, Orkin SH.

Nat Genet. 2005 Jun;37(6):613-9.

PMID:
15895080
8.

A novel mutation in the GATA1 gene associated with acute megakaryoblastic leukemia in a Korean Down syndrome patient.

Kim IS, Park ES, Lim JY, Ki CS, Chi HS.

J Korean Med Sci. 2008 Dec;23(6):1105-8. doi: 10.3346/jkms.2008.23.6.1105.

9.

Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome.

Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C.

Blood. 2007 Sep 15;110(6):2128-31.

10.

Mutations in GATA1 in both transient myeloproliferative disorder and acute megakaryoblastic leukemia of Down syndrome.

Greene ME, Mundschau G, Wechsler J, McDevitt M, Gamis A, Karp J, Gurbuxani S, Arceci R, Crispino JD.

Blood Cells Mol Dis. 2003 Nov-Dec;31(3):351-6.

PMID:
14636651
11.

Origins of leukaemia in children with Down syndrome.

Hitzler JK, Zipursky A.

Nat Rev Cancer. 2005 Jan;5(1):11-20. Review.

PMID:
15630411
12.

GATA1 as a new target to detect minimal residual disease in both transient leukemia and megakaryoblastic leukemia of Down syndrome.

Pine SR, Guo Q, Yin C, Jayabose S, Levendoglu-Tugal O, Ozkaynak MF, Sandoval C.

Leuk Res. 2005 Nov;29(11):1353-6.

PMID:
15916804
13.

The GATA1 mutation in an adult patient with acute megakaryoblastic leukemia not accompanying Down syndrome.

Harigae H, Xu G, Sugawara T, Ishikawa I, Toki T, Ito E.

Blood. 2004 Apr 15;103(8):3242-3. No abstract available.

14.

Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.

Sandoval C, Pine SR, Guo Q, Sastry S, Stewart J, Kronn D, Jayabose S.

Pediatr Blood Cancer. 2005 Jan;44(1):85-91. Review.

PMID:
15390279
15.

GATA1 mutations in patients with down syndrome and acute megakaryoblastic leukaemia do not always confer a good prognosis.

Ariffin H, Garcia JC, Daud SS, Ibrahim K, Aizah N, Ong GB, Chong LA, Mohamad Z.

Pediatr Blood Cancer. 2009 Jul;53(1):108-11. doi: 10.1002/pbc.21983.

PMID:
19260099
16.

A leukemogenic twist for GATA1.

Look AT.

Nat Genet. 2002 Sep;32(1):83-4. No abstract available.

PMID:
12172549
17.

Abnormalities in the myeloid progenitor compartment in Down syndrome fetal liver precede acquisition of GATA1 mutations.

Tunstall-Pedoe O, Roy A, Karadimitris A, de la Fuente J, Fisk NM, Bennett P, Norton A, Vyas P, Roberts I.

Blood. 2008 Dec 1;112(12):4507-11. doi: 10.1182/blood-2008-04-152967.

18.

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.

Roy A, Roberts I, Norton A, Vyas P.

Br J Haematol. 2009 Oct;147(1):3-12. doi: 10.1111/j.1365-2141.2009.07789.x. Review.

PMID:
19594743
20.

Physical association of the patient-specific GATA1 mutants with RUNX1 in acute megakaryoblastic leukemia accompanying Down syndrome.

Xu G, Kanezaki R, Toki T, Watanabe S, Takahashi Y, Terui K, Kitabayashi I, Ito E.

Leukemia. 2006 Jun;20(6):1002-8.

PMID:
16628190

Supplemental Content

Support Center